To view the PDF file, sign up for a MySharenet subscription.

JSE LIMITED - Dealings in securities by directors, the company secretary and the JSE LTIS 2010 Trust

Release Date: 07/03/2017 16:52
Code(s): JSE     PDF:  
Wrap Text
Dealings in securities by directors, the company secretary and the JSE LTIS 2010 Trust

JSE Limited
(Incorporated in the Republic of South Africa)
(Registration number: 2005/022939/06)
ISIN: ZAE000079711
Share Code: JSE
("JSE" or “the Company”)

DEALINGS IN SECURITIES BY DIRECTORS, THE COMPANY SECRETARY AND THE JSE
LTIS 2010 TRUST

The JSE LTIS 2010 Trust (“Trust”) has acquired a total of 290 530 JSE
ordinary shares in the open market on behalf of 43 senior members of JSE
staff (“LTIS 2010 participants”) to fulfil share awards granted to these
staff under the JSE’s Long-Term Incentive Scheme (“LTIS 2010”). This
acquisition of JSE ordinary shares includes allocations to members of the
JSE executive committee as disclosed below.

These ordinary shares are held in trust and are restricted until all
vesting criteria are fulfilled whereupon the shares vest. To the extent
that the vesting criteria are not fulfilled the share awards are
forfeited.

The vesting of these restricted JSE ordinary shares is subject to –

(i)  the JSE achieving specified corporate performance targets over the
     measurement period; and
(ii) a LTIS 2010 participant remaining in the employ of the JSE for the
     vesting term (collectively “the vesting criteria”).

These JSE ordinary shares were acquired on-market, with clearance, at a
volume-weighted average price of R147.92 per ordinary share. The total
transaction value amounted to R42 975 652.79.    The daily high, low and
volume-weighted average for the various transactions were –


Date in 2017
    that JSE           Number of JSE                         Daily high    Daily low
    ordinary                ordinary         Daily VWAP      price paid   price paid
      shares                  shares         (cents per      (cents per   (cents per
    acquired                acquired             share)         share)       share)
                                           
    

     2 March                 135 787              14903           14973        14845

     3 March                 154 743              14695           14825        14650




The requisite approvals have been granted by shareholders at the
Company’s annual general meeting, in respect of the acquisition of JSE
ordinary shares in the open market and in respect of specific financial
assistance to the Trust for the purpose of acquiring these shares.


ACCEPTANCE OF ALLOCATIONS OF SECURITIES TO DIRECTORS, THE COMPANY
SECRETARY AND PRESCRIBED OFFICERS

Following the acquisition of the JSE ordinary shares by the Trust as
disclosed above, members of the JSE’s executive committee, which includes
the executive directors and Company Secretary, have on 3 March 2017
accepted grants of restricted ordinary shares in the Company, as
reflected in this announcement.


                                          Total number
                                         of restricted        Total Rand value
                                          JSE ordinary       of restricted JSE
Executive                                       shares         ordinary shares
Committee                                  awarded and             awarded and         Nature of
member             Role                       accepted                accepted          interest
                                                                      
                                        
                   CEO & Executive                                                    Direct
NF Newton-King     Director                     33 020               4 884 318        beneficial
                                                                                      
                   CFO & Executive                                                    Direct
A Takoordeen       Director                     12 010               1 776 519        beneficial
                                                                                      
                   Alternate                                                          Direct
JH Burke           Director                     13 240               1 958 461        beneficial
                                                                                      
                   Alternate                                                          Direct
LV Parsons         Director                     14 240               2 106 381        beneficial
                                                                                      
                   Prescribed                                                         Direct
A Greenwood        Officer                      12 780               1 890 418        beneficial
                                                                                      
                   Prescribed                                                         Direct
ZA Jacobs          Officer                      11 460               1 695 163        beneficial
                                                                                      
                   Prescribed                                                         Direct
D Khumalo          Officer                       9 480               1 402 282        beneficial
                                                                                      
                   Prescribed                                                         Direct
TJ Matsena         Officer                       9 650               1 427 428        beneficial
                                                                                      
                   Prescribed                                                         Direct
DM Nemer           Officer                      14 570               2 155 194        beneficial
                                                                                      
                   Prescribed                                                         Direct
RJ van Wamelen     Officer                      13 260               1 961 419        beneficial
                                                                                      
                                                                                      Direct
GA Brookes         Company Secretary             9 920               1 467 366        beneficial
                                                                                      



The restricted shares will vest in two tranches, one-half on 1 March 2020
and the remaining half on 1 March 2021, subject to the vesting criteria
as set out above being met.

The individual allocations (grant and acceptance) were approved by the
JSE Group Human Resources Committee and clearance to deal was granted by
the Chairman of the Board.


DEALING IN SECURITIES BY PRESCRIBED OFFICER

In compliance with the JSE Limited Listing Requirements the following
information is disclosed:

Prescribed officer:             TJ Matsena
Company:                        JSE Limited
Date of transaction:            3 March 2017
Nature of transaction:          On-market purchase of securities
Number of securities:           2 000
Class of securities:            JSE ordinary shares
Purchase price
(volume weighted average):      14709 cents per share
Total value of transaction:     R294 187.87
Highest purchase price:         14728 cents per share
Lowest purchase price:          14680 cents per share
Nature of interest:             Direct beneficial
Clearance obtained:             Yes



Sandton
7 March 2017


Sponsor
RAND MERCHANT BANK (A division of FirstRand Bank Limited)

Date: 07/03/2017 04:52:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Share This Story